n.a. (QLTI)

0.00
NASDAQ
Prev Close 0.00
Day Low/High 0.00 / 0.00
52 Wk Low/High 0.00 / 0.00
Exchange NASDAQ
Div & Yield N.A. (N.A)
Health Stocks in Motion

Health Stocks in Motion

Martek plunges 44% after warning that third-quarter sales would be below expectations.

Health Stocks in Motion

Health Stocks in Motion

LanVision surges on an IBM partnership.

QLT Finance Chief Leaving

QLT Finance Chief Leaving

Mike Doty will be missed, the Vancouver biotech indicates.

Oversold Stocks Due for a Rebound

Charlotte Russe, Adtran and others look like good reversal candidates on any market strength.

Nasdaq's Bounce Heartens Bulls

But the index has a lot of ground to make up. Plus survey results, Geron and more.

Eyetech Jumps on FDA OK

Eyetech Jumps on FDA OK

The company wins regulatory approval for its vision loss drug Macugen.

Alcon Eye-Drug Setback Raises the Stakes

Alcon Eye-Drug Setback Raises the Stakes

Shares working with other companies on a treatment for wet macular degeneration gain.

Eyetech Falls in Wake of FDA Panel Meeting

Eyetech Falls in Wake of FDA Panel Meeting

Analysts say the company's eye treatment has a good chance of getting FDA approval.

Eyetech Holders Eye FDA Panel

Eyetech Holders Eye FDA Panel

Its shares have soared on the promise of its new drug, making this week's FDA panel key.

QLT to Buy Atrix Labs

QLT to Buy Atrix Labs

The price is about $35.63 in stock and cash.

Preparing for the Next Breakout

While not a risk-free strategy, trading stocks that have broken a range can pay off.

QLT Drops on Lower Revenue Estimates

QLT Drops on Lower Revenue Estimates

Human Genome Raises $825 Million in Secondary Offering

Human Genome Raises $825 Million in Secondary Offering

The proceeds will be used for research and development.

QLT Shares Surge as Investors Eye Strong Sales

QLT Shares Surge as Investors Eye Strong Sales

Visudyne's success hinges on doctors buying pricey equipment.

Biotechs Backing Off After a Long Rally

Biotechs Backing Off After a Long Rally

Some analysts see money moving out of the sector and into tech and Net stocks.